Identification of Novel Candidate Genes for Early-Onset Colorectal Cancer Susceptibility

Approximately 25–30% of colorectal cancer (CRC) cases are expected to result from a genetic predisposition, but in only 5–10% of these cases highly penetrant germline mutations are found. The remaining CRC heritability is still unexplained, and may be caused by a hitherto-undefined set of rare variants with a moderately penetrant risk. Here we aimed to identify novel risk factors for early-onset CRC using whole-exome sequencing, which was performed on a cohort of CRC individuals (n = 55) with a disease onset before 45 years of age. We searched for genes that were recurrently affected by rare variants (minor allele frequency 0.001) with potentially damaging effects and, subsequently, re-sequenced the candidate genes in a replication cohort of 174 early-onset or familial CRC individuals. Two functionally relevant genes with low frequency variants with potentially damaging effects, PTPN12 and LRP6, were found in at least three individuals. The protein tyrosine phosphatase PTP-PEST, encoded by PTPN12, is a regulator of cell motility and LRP6 is a component of the WNT-FZD-LRP5-LRP6 complex that triggers WNT signaling. All variants in LRP6 were identified in individuals with an extremely early-onset of the disease ( 30 years of age), and two of the three variants showed increased WNT signaling activity in vitro. In conclusion, we present PTPN12 and LRP6 as novel candidates contributing to the heterogeneous susceptibility to CRC.

[1]  M. Maurice,et al.  Loss-of-Function Mutations in the WNT Co-receptor LRP6 Cause Autosomal-Dominant Oligodontia. , 2015, American journal of human genetics.

[2]  A. Hoischen,et al.  Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer , 2015, Scientific Reports.

[3]  A. Gylfason,et al.  Loss-of-function variants in ATM confer risk of gastric cancer , 2015, Nature Genetics.

[4]  J. Shendure,et al.  A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer , 2015, Nature Genetics.

[5]  R. Kuiper,et al.  Candidate colorectal cancer predisposing gene variants in Chinese early-onset and familial cases. , 2015, World journal of gastroenterology.

[6]  M. Speicher,et al.  Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X , 2014, Nature Communications.

[7]  Á. Carracedo,et al.  Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer , 2014, Genetics in Medicine.

[8]  Yan Guo,et al.  Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk , 2014, Nature Genetics.

[9]  D. G. MacArthur,et al.  Guidelines for investigating causality of sequence variants in human disease , 2014, Nature.

[10]  P. Anastasiadis,et al.  PTP-PEST targets a novel tyrosine site in p120 catenin to control epithelial cell motility and Rho GTPase activity , 2014, Journal of Cell Science.

[11]  Nazneen Rahman,et al.  Realizing the promise of cancer predisposition genes , 2014, Nature.

[12]  Peggy Hall,et al.  The NHGRI GWAS Catalog, a curated resource of SNP-trait associations , 2013, Nucleic Acids Res..

[13]  Christian Gilissen,et al.  A Post‐Hoc Comparison of the Utility of Sanger Sequencing and Exome Sequencing for the Diagnosis of Heterogeneous Diseases , 2013, Human mutation.

[14]  L. Aaltonen,et al.  Eleven Candidate Susceptibility Genes for Common Familial Colorectal Cancer , 2013, PLoS genetics.

[15]  L. Vreede,et al.  Germline mutations in the spindle assembly checkpoint genes BUB1 and BUB3 are risk factors for colorectal cancer. , 2013, Gastroenterology.

[16]  Howard L McLeod,et al.  Exome Resequencing Identifies Potential Tumor‐Suppressor Genes that Predispose to Colorectal Cancer , 2013, Human mutation.

[17]  Peter Donnelly,et al.  Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas , 2013, Nature Genetics.

[18]  D. Schaid,et al.  Identification of Novel Variants in Colorectal Cancer Families by High-Throughput Exome Sequencing , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[19]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[20]  B. V. van Bon,et al.  Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, The New England journal of medicine.

[21]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[22]  Steven Hawken,et al.  Systematic meta-analyses and field synopsis of genetic association studies in colorectal cancer. , 2012, Journal of the National Cancer Institute.

[23]  R. Pai,et al.  Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features , 2012, Modern Pathology.

[24]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[25]  Jacob A. Tennessen,et al.  Evolution and Functional Impact of Rare Coding Variation from Deep Sequencing of Human Exomes , 2012, Science.

[26]  Hans Clevers,et al.  Wnt/β-Catenin Signaling and Disease , 2012, Cell.

[27]  Steven Gallinger,et al.  Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk , 2012, Nature Genetics.

[28]  A. Clark,et al.  Recent Explosive Human Population Growth Has Resulted in an Excess of Rare Genetic Variants , 2012, Science.

[29]  Joseph K. Pickrell,et al.  A Systematic Survey of Loss-of-Function Variants in Human Protein-Coding Genes , 2012, Science.

[30]  A. Rust,et al.  Insertional mutagenesis identifies multiple networks of co-operating genes driving intestinal tumorigenesis , 2011, Nature Genetics.

[31]  R. Moon,et al.  Crystal structures of the extracellular domain of LRP6 and its complex with DKK1 , 2011, Nature Structural &Molecular Biology.

[32]  Paul Flicek,et al.  The functional spectrum of low-frequency coding variation , 2011, Genome Biology.

[33]  S. Navani,et al.  The human protein atlas , 2011 .

[34]  M. Rao,et al.  Activation of Multiple Proto-oncogenic Tyrosine Kinases in Breast Cancer via Loss of the PTPN12 Phosphatase , 2011, Cell.

[35]  Christian Gilissen,et al.  A de novo paradigm for mental retardation , 2010, Nature Genetics.

[36]  J. Phillips,et al.  EMR-3: a potential mediator of invasive phenotypic variation in glioblastoma and novel therapeutic target , 2010, Neuroreport.

[37]  Gert Vriend,et al.  Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces , 2010, BMC Bioinformatics.

[38]  B. Evers,et al.  PTP-PEST controls motility, adherens junction assembly, and Rho GTPase activity in colon cancer cells. , 2010, American journal of physiology. Cell physiology.

[39]  Olivia Fletcher,et al.  Architecture of inherited susceptibility to common cancer , 2010, Nature Reviews Cancer.

[40]  Judy H. Cho,et al.  Finding the missing heritability of complex diseases , 2009, Nature.

[41]  K. Aldape,et al.  FAK phosphorylation by ERK primes ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PEST. , 2009, Molecular cell.

[42]  Y. Asmann,et al.  A Transposon-Based Genetic Screen in Mice Identifies Genes Altered in Colorectal Cancer , 2009, Science.

[43]  L. Tan,et al.  Potential Molecular Mechanism for c-Src Kinase-mediated Regulation of Intestinal Cell Migration* , 2008, Journal of Biological Chemistry.

[44]  J. Iovanna,et al.  ArgBP2-dependent signaling regulates pancreatic cell migration, adhesion, and tumorigenicity. , 2008, Cancer research.

[45]  T. Shohat,et al.  Prevalence of breast and colorectal cancer in Ashkenazi Jewish carriers of Fanconi anemia and Bloom syndrome. , 2007, The Israel Medical Association journal : IMAJ.

[46]  A. Verhoeven,et al.  The human EGF‐TM7 receptor EMR3 is a marker for mature granulocytes , 2007, Journal of leukocyte biology.

[47]  A. Ullrich,et al.  PTP-PEST phosphatase variations in human cancer. , 2006, Cancer genetics and cytogenetics.

[48]  S. Gallinger,et al.  Heterozygosity for the BLMAsh Mutation and Cancer Risk , 2003 .

[49]  Ajamete Kaykas,et al.  Zebrafish Prickle, a Modulator of Noncanonical Wnt/Fz Signaling, Regulates Gastrulation Movements , 2003, Current Biology.

[50]  P. Gregersen,et al.  BLM Heterozygosity and the Risk of Colorectal Cancer , 2002, Science.

[51]  Yan Li,et al.  LDL-receptor-related protein 6 is a receptor for Dickkopf proteins , 2001, Nature.

[52]  S. Bull,et al.  Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. , 2000, The New England journal of medicine.

[53]  G. Thomas,et al.  [Genetic predisposition to colorectal cancer]. , 1993, Annales de gastroenterologie et d'hepatologie.

[54]  L. Aaltonen,et al.  Systematic search for rare variants in Finnish early-onset colorectal cancer patients. , 2015, Cancer genetics.

[55]  T. Dickhaus,et al.  Estimating exome genotyping accuracy by comparing to data from large scale sequencing projects , 2013 .

[56]  Yuchen Jiao,et al.  ATM mutations in patients with hereditary pancreatic cancer. , 2012, Cancer discovery.

[57]  D. Stoppa-Lyonnet,et al.  ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy , 2009, Breast Cancer Research and Treatment.

[58]  R. Fitzgibbons,et al.  Hereditary Colorectal Cancer , 1990, Springer Japan.